CA125 normalization within 60 days as an independent prognostic factor for patients with advanced epithelial ovarian cancer.

Liao, Yi-Chiao; Ou, Yu-Che; Wu, Chen-Hsuan; Fu, Hung-Chun; Tsai, Ching-Chou; Lin, Hao

Liao, Yi-Chiao; Ou, Yu-Che; Wu, Chen-Hsuan; Fu, Hung-Chun; Tsai, Ching-Chou; Lin, Hao.

Afiliación

Liao YC; Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Ou YC; Department of Obstetrics and Gynecology, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
Wu CH; Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Fu HC; Department of Obstetrics and Gynecology, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
Tsai CC; Department of Obstetrics and Gynecology, Chia-Yi Chang Gung Memorial Hospital, Chia-Yi, Taiwan.
Lin H; Department of Obstetrics and Gynecology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.

Cancer Biomark ; 32(4): 559-567, 2021.

Article en En | MEDLINE | ID: mdl-34397404

Asunto(s)

Antígeno Ca-125/metabolismo; Carcinoma Epitelial de Ovario/sangre; Adulto; Anciano; Anciano de 80 o más Años; Carcinoma Epitelial de Ovario/fisiopatología; Femenino; Humanos; Persona de Mediana Edad; Pronóstico; Estudios Retrospectivos; Factores de Tiempo

Palabras clave

Epithelial ovarian cancer; advanced ovarian cancer; carbohydrate antigen 125; normalization; survival outcome

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Antígeno Ca-125 / Carcinoma Epitelial de Ovario Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Cancer Biomark Asunto de la revista: BIOQUIMICA / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google